US FDA Commissioner Scott Gottlieb’s proposal for a subscription model for hospital purchasing of antibiotics could help shore up the market, but industry experts think additional incentives are needed.
Reimbursement for antibiotics, particularly at hospitals, is among the factors limiting the antibiotic market and holding
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?